These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24976020)

  • 1. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: comment.
    Tardy B; Chalayer E; Chapelle C; Mismetti P
    J Thromb Haemost; 2014 Sep; 12(9):1572-3. PubMed ID: 24976020
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials: reply.
    Sanford D; Lazo-Langner A
    J Thromb Haemost; 2014 Sep; 12(9):1574-5. PubMed ID: 25039759
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials.
    Sanford D; Naidu A; Alizadeh N; Lazo-Langner A
    J Thromb Haemost; 2014 Jul; 12(7):1076-85. PubMed ID: 24796727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin and survival in patients with malignant disease.
    Kakkar AK
    Cancer Control; 2005 Sep; 12 Suppl 1():22-30. PubMed ID: 16179901
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute venous thrombosis: new directions in prophylaxis and treatment].
    Fedorov VD; Titiova MI; Ganzha PF
    Khirurgiia (Mosk); 1998; (12):60-3. PubMed ID: 9916443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparin and cancer].
    Lykke J
    Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
    Lee AY
    Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
    [No Abstract]   [Full Text] [Related]  

  • 9. Does low-molecular-weight heparin influence cancer-related mortality?
    Meyer G
    Ann Oncol; 2007 Mar; 18(3):609-10. PubMed ID: 17322543
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment guidelines for deep venous thrombosis and pulmonary embolus].
    Harjola VP; Teittinen J
    Duodecim; 2001; 117(24):2603-10. PubMed ID: 12183822
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin K antagonists in anticoagulant therapy of patients with cancer.
    Pasierski T
    Pol Arch Med Wewn; 2012; 122(1-2):60-4. PubMed ID: 22353708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in cirrhosis.
    Villa E; De Maria N
    Liver Int; 2012 Jul; 32(6):878-9. PubMed ID: 22672641
    [No Abstract]   [Full Text] [Related]  

  • 14. Should patients with venous thromboembolism and cancer be treated differently?
    Smorenburg SM; Hutten BA; Prins MH
    Haemostasis; 1999 Dec; 29 Suppl S1():91-7. PubMed ID: 10629414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-basis for anticoagulants for cerebral sinus venous thrombosis?
    Cundiff DK
    Stroke; 2013 Jun; 44(6):e67. PubMed ID: 23592764
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to evidence-basis for anticoagulants for cerebral sinus venous thrombosis?
    Coutinho JM; Bousser MG; Stam J
    Stroke; 2013 Jun; 44(6):e68. PubMed ID: 23686970
    [No Abstract]   [Full Text] [Related]  

  • 17. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
    Caine GJ; Lip GY
    Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.
    Iorio A; Guercini F; Pini M
    J Thromb Haemost; 2003 Sep; 1(9):1906-13. PubMed ID: 12941030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants and cancer survival.
    Piccioli A; Falanga A; Prandoni P
    Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence basis for anticoagulants for cerebral sinus venous thrombosis? Reply to David K. Cundiff.
    Ferro JM; Canhão P
    Stroke; 2013 Nov; 44(11):e150. PubMed ID: 24085028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.